Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Peter Wolfe currently holds 715 shares of ZyVersa Therapeutics, Inc. (ZVSA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Peter Wolfe has been a net neutral trader of ZVSA stock. They have purchased $0 and sold $0 worth of shares.
Peter Wolfe's most recent insider trade was on May 24, 2023, when they sold 715 shares at $0.00 per share.
Peter Wolfe serves as Executive at ZyVersa Therapeutics, Inc. (ZVSA). They have executed 3 insider transactions totaling $0 over their tenure at the company.
Peter Wolfe holds the position of Executive at ZyVersa Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Peter Wolfe has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Peter Wolfe was on Dec 16, 2022, when they purchased $8.6K worth of ZVSA shares. This transaction involved 3,000 shares at $2.88 per share.
Peter Wolfe currently owns 715 shares of ZyVersa Therapeutics, Inc. (ZVSA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Peter Wolfe's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Peter Wolfe has 3 Form 4 filings on record as an insider at ZyVersa Therapeutics, Inc..
Set alerts for Peter Wolfe and 40,000+ other insiders.